about
Cardiovascular safety of anti-diabetic drugsGut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutideHorizons in the Pharmacotherapy of Obesity.Lipopeptides as therapeutics: applications and in vivo quantitative analysis.2014 EASO Position Statement on the Use of Anti-Obesity Drugs.Liraglutide suppresses proliferation and induces adipogenic differentiation of 3T3-L1 cells via the Hippo-YAP signaling pathway.
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Liraglutide in the treatment of obesity.
@en
type
label
Liraglutide in the treatment of obesity.
@en
prefLabel
Liraglutide in the treatment of obesity.
@en
P2860
P1476
Liraglutide in the treatment of obesity
@en
P2093
Sarah Yoon Ai Ng
P2860
P304
P356
10.1517/14712598.2014.925870
P407
P50
P577
2014-06-06T00:00:00Z